Back to Newsroom

Catalyst Pharmaceuticals to Participate in the 28th Annual Piper Jaffray Healthcare Conference

CORAL GABLES, Fla., Nov. 21, 2016 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Steven Miller, Ph.D., Chief Operating Officer and Chief Scientific Officer, will participate as part of the Underdiscovered Neuro-Innovators Panel at the 28th Annual Piper Jaffray Healthcare Conference being held at Lotte New York Palace, NY, November 29-30.  The panel will take place Tuesday, November 29 at 10 am EST.

Click here to read the full release